
Tactile Systems Technology Inc
NASDAQ:TCMD

Tactile Systems Technology Inc
EPS (Diluted)
Tactile Systems Technology Inc
EPS (Diluted) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | EPS (Diluted) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Tactile Systems Technology Inc
NASDAQ:TCMD
|
EPS (Diluted)
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
![]() |
Becton Dickinson and Co
NYSE:BDX
|
EPS (Diluted)
$6
|
CAGR 3-Years
1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
0%
|
|
![]() |
Boston Scientific Corp
NYSE:BSX
|
EPS (Diluted)
$1
|
CAGR 3-Years
22%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
|
![]() |
Stryker Corp
NYSE:SYK
|
EPS (Diluted)
$7
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
19%
|
|
![]() |
Abbott Laboratories
NYSE:ABT
|
EPS (Diluted)
$7
|
CAGR 3-Years
25%
|
CAGR 5-Years
30%
|
CAGR 10-Years
18%
|
|
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
EPS (Diluted)
$6
|
CAGR 3-Years
11%
|
CAGR 5-Years
11%
|
CAGR 10-Years
18%
|
Tactile Systems Technology Inc
Glance View
Tactile Systems Technology, Inc. is a medical technology company. The company is headquartered in Minneapolis, Minnesota and currently employs 988 full-time employees. The company went IPO on 2016-07-28. Its therapeutic focus is vascular disease, for treating lymphedema and chronic venous insufficiency. The company is a manufacturer and distributor of the Flexitouch and Entre systems, medical devices that help control symptoms of lymphedema, a chronic and progressive medical condition. Its at-home Flexitouch system provides automated, at-home lymphatic drainage therapy. Its Flexitouch Plus system is an automated, programmable, pneumatic compression device (APCD), designed for the treatment of lymphedema in the home setting. Its Entre system is a pneumatic compression device used for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company possesses a platform to deliver at-home healthcare solutions directly to patients throughout the United States.

See Also
What is Tactile Systems Technology Inc's EPS (Diluted)?
EPS (Diluted)
0.7
USD
Based on the financial report for Dec 31, 2024, Tactile Systems Technology Inc's EPS (Diluted) amounts to 0.7 USD.
What is Tactile Systems Technology Inc's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
5%
Over the last year, the EPS (Diluted) growth was -43%.